Chris Bowden

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism

Agnes Lee, Frederick R. Rickles, Jim A. Julian et al. · Journal of Clinical Oncology · 2005 · 453 citations · Full text

Medicine, Oncology, Pharmacology +13

Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat et al. · Journal of Clinical Oncology · 2020 · 307 citations · Full text

Medicine, Oncology, Pharmacology +16

ATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With Bevacizumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Bruce E. Johnson, Fairooz F. Kabbinavar, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2013 · 209 citations · Full text

Medicine, Oncology, Pharmacology +13

Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML

Sung Choe, Hongfang Wang, Courtney D. DiNardo et al. · Blood Advances · 2020 · 195 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15